Here are the DEF 14A proxy statements from BrightSpring Health Services, Inc. Tangible Equity Unit (BTSGU) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow BTSGU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BTSGU filings page.
BrightSpring Health Services, Inc. is asking stockholders to vote at its virtual Annual Meeting on May 21, 2026 on three items: electing three Class II directors to serve until 2029, ratifying KPMG LLP as independent auditor for 2026, and approving on an advisory basis executive compensation.
The company reports strong 2025 performance, with revenue rising to $12.9 billion and Adjusted EBITDA increasing to $618 million, driven mainly by its pharmacy solutions and provider services segments. Executive pay centers on a short‑term incentive plan tied to EBITDA, revenue growth and a quality index, with CEO base salary set at $1.4 million and a 150% target bonus opportunity. BrightSpring is no longer a Nasdaq “controlled company” after the KKR stockholder fell below majority ownership in 2025, and has formed fully independent audit and compensation committees while using a transition period to finalize a nominating and governance charter.